Westview Health Care Center | |
1990 West Loucks Street, Sheridan, Wyoming 82801 | |
(307) 672-9789 | |
Name | Westview Health Care Center |
---|---|
Location | 1990 West Loucks Street, Sheridan, Wyoming |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 102 |
Occupancy Rate | 49.41% |
Medicare ID (CCN) | 535039 |
Legal Business Name | Westview Operations Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1083771679 |
Organization Name | LIFE CARE CENTERS OF AMERICA, INC. |
Doing Business As | WESTVIEW HEALTH CARE CENTER |
Address | 1990 W Loucks St, Sheridan, WY 82801 |
Phone Number | 307-672-9789 |
News Archive
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
Serco has been selected by NHS Suffolk to provide services including district nurses and community hospitals. Serco won the contract worth around £140 million. Services are currently provided by Suffolk Community Healthcare (SCH), part of NHS Suffolk, and will transfer by this autumn.
Wake Forest Baptist Medical Center is the first medical center in the United States to offer the FDA-cleared DigniCap scalp cooling system to patients undergoing chemotherapy for breast cancer.
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 7 days ago
NPI Number | 1972964831 |
Organization Name | WESTVIEW OPERATIONS, LLC |
Doing Business As | WESTVIEW HEALTH CARE CENTER |
Address | 1990 W Loucks St, Sheridan, WY 82801 |
Phone Number | 307-672-9789 |
News Archive
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
Serco has been selected by NHS Suffolk to provide services including district nurses and community hospitals. Serco won the contract worth around £140 million. Services are currently provided by Suffolk Community Healthcare (SCH), part of NHS Suffolk, and will transfer by this autumn.
Wake Forest Baptist Medical Center is the first medical center in the United States to offer the FDA-cleared DigniCap scalp cooling system to patients undergoing chemotherapy for breast cancer.
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
Serco has been selected by NHS Suffolk to provide services including district nurses and community hospitals. Serco won the contract worth around £140 million. Services are currently provided by Suffolk Community Healthcare (SCH), part of NHS Suffolk, and will transfer by this autumn.
Wake Forest Baptist Medical Center is the first medical center in the United States to offer the FDA-cleared DigniCap scalp cooling system to patients undergoing chemotherapy for breast cancer.
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $43186 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.59 | 14.46 |
Percentage of long-stay residents who lose too much weight | 1.71 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.89 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.69 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.29 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 13.11 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.14 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 17.68 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 4.08 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 11.81 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.63 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.8 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.2 | 95.98 |
Percentage of short-stay residents who made improvements in function | 65.76 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.34 | 82.93 |
News Archive
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
Serco has been selected by NHS Suffolk to provide services including district nurses and community hospitals. Serco won the contract worth around £140 million. Services are currently provided by Suffolk Community Healthcare (SCH), part of NHS Suffolk, and will transfer by this autumn.
Wake Forest Baptist Medical Center is the first medical center in the United States to offer the FDA-cleared DigniCap scalp cooling system to patients undergoing chemotherapy for breast cancer.
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 7 days ago
Big Horn Rehabilitation And Care Center Location: 1851 Big Horn Ave, Sheridan, Wyoming 82801 Phone: (307) 674-4416 | |
Westview Health Care Center Location: 1990 West Loucks Street, Sheridan, Wyoming 82801 Phone: (307) 672-9789 | |
Green House Living For Sheridan Location: 2311 Shirley Cove, Sheridan, Wyoming 82801 Phone: (307) 672-0600 |